Sunnylife branches out.Sunnylife Global Inc., which operates a joint venture bringing U.S. style-managed health care to hospitals in China, recently made two moves designed to further the Los Angeles-based company's China-focused pharmaceutical business. Suunylife Global, founded by two Los Angeles-area doctors who are natives of what is now mainland China, said it has signed a joint venture agreement with Shandong Luyin Pharmaceutical Co. in Shandong province. The agreement will help modernize mod·ern·ize v. mo·dern·ized, mo·dern·iz·ing, mo·dern·iz·es v.tr. To make modern in appearance, style, or character; update. v.intr. To accept or adopt modern ways, ideas, or style. development and manufacture of Shandong Luyin's Chinese herb herb (ûrb, hûrb), name for any plant that is used medicinally or as a spice and for the useful product of such a plant. Herbs as condiments and seasonings are still important in culinary art; the use of medicinal herbs, however, has waned medication and biotechnology products. Sunnylife expects the new company's products will become a preferred provider in the Chinese hospitals that Sunnylife is converting to modified HMO HMO health maintenance organization. HMO n. A corporation that is financed by insurance premiums and has member physicians and professional staff who provide curative and preventive medicine within certain financial, model. Shandong Luyin has 17 Chinese government-approved products in treatment areas ranging from cardiovascular and metabolism metabolism, sum of all biochemical processes involved in life. Two subcategories of metabolism are anabolism, the building up of complex organic molecules from simpler precursors, and catabolism, the breakdown of complex substances into simpler molecules, often regulation to tumor tumor: see neoplasm. suppression. In addition, Sunnylife said it has opened an office in Taiwan to expand its access to that country's growing biotechnology research, development and commercialization sector. Staff reporter Deborah Crowe can be reached at (323) 549-5255, ext. 232, or at dcrowe@labusinessjournal.com. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion